Fierce Biotech May 16, 2024
The startup May Health has gathered $25 million in funding to help continue clinical studies of its less invasive, outpatient procedure for addressing infertility caused by polycystic ovary syndrome, the endocrine disorder commonly known as PCOS.
The former Fierce Medtech Fierce 15 winner, previously known as AblaCare, has been developing its “ovarian rebalancing” approach that aims to restore a person’s natural ovulation cycle.
“For the millions of women living with PCOS, the physical and emotional impact of this condition is profound,” May Health CEO Anne Morrissey said in a statement. “From fertility challenges to emotional well-being and physical symptoms, women with PCOS need more viable treatment options.”
“We are eager to continue building on the positive results of our...
Today's Sponsors
Today's Sponsor